252 related articles for article (PubMed ID: 32030564)
21. Topically applied treatments for external genital warts in nonimmunocompromised patients: a systematic review and network meta-analysis.
Jung JM; Jung CJ; Lee WJ; Won CH; Lee MW; Choi JH; Chang SE
Br J Dermatol; 2020 Jul; 183(1):24-36. PubMed ID: 31675442
[TBL] [Abstract][Full Text] [Related]
22. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Guelimi R; Garcia-Doval I; Hua C; Hughes C; Naldi L; Kinberger M; Afach S; Le Cleach L
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD011535. PubMed ID: 37436070
[TBL] [Abstract][Full Text] [Related]
23. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis.
Piechotta V; Adams A; Haque M; Scheckel B; Kreuzberger N; Monsef I; Jordan K; Kuhr K; Skoetz N
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012775. PubMed ID: 34784425
[TBL] [Abstract][Full Text] [Related]
24. Intralesional injection of Mycobacterium w vaccine vs imiquimod, 5%, cream in patients with anogenital warts: a randomized clinical trial.
Kumar P; Dar L; Saldiwal S; Varma S; Datt Upadhyay A; Talwar D; Sharma VK; Verma KK; Dwivedi SN; Raj R; Gupta S
JAMA Dermatol; 2014 Oct; 150(10):1072-8. PubMed ID: 25103148
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulators and immunosuppressants for relapsing-remitting multiple sclerosis: a network meta-analysis.
Tramacere I; Del Giovane C; Salanti G; D'Amico R; Filippini G
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD011381. PubMed ID: 26384035
[TBL] [Abstract][Full Text] [Related]
26. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
27. Interventions for mycosis fungoides: critical commentary on a Cochrane Systematic Review.
Wu PA; Huang V; Bigby ME
Br J Dermatol; 2014 May; 170(5):1015-20. PubMed ID: 24841586
[TBL] [Abstract][Full Text] [Related]
28. Methodological quality of systematic reviews of the local management of anogenital warts: a systematic review using AMSTAR II, ROBIS and PRISMA.
Desmoulin A; Joly E; Tran P; Derancourt C; Bertolotti A
Sex Transm Infect; 2023 Aug; 99(5):345-347. PubMed ID: 36948589
[TBL] [Abstract][Full Text] [Related]
29. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
[TBL] [Abstract][Full Text] [Related]
30. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
Edwards L; Ferenczy A; Eron L; Baker D; Owens ML; Fox TL; Hougham AJ; Schmitt KA
Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
[TBL] [Abstract][Full Text] [Related]
31. Meta-analysis of 5% imiquimod and 0.5% podophyllotoxin in the treatment of condylomata acuminata.
Yan J; Chen SL; Wang HN; Wu TX
Dermatology; 2006; 213(3):218-23. PubMed ID: 17033171
[TBL] [Abstract][Full Text] [Related]
32. Medical interventions for high-grade vulval intraepithelial neoplasia.
Pepas L; Kaushik S; Nordin A; Bryant A; Lawrie TA
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007924. PubMed ID: 26284429
[TBL] [Abstract][Full Text] [Related]
33. Interventions for actinic keratoses.
Gupta AK; Paquet M; Villanueva E; Brintnell W
Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
[TBL] [Abstract][Full Text] [Related]
34. Interventions for convergence insufficiency: a network meta-analysis.
Scheiman M; Kulp MT; Cotter SA; Lawrenson JG; Wang L; Li T
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD006768. PubMed ID: 33263359
[TBL] [Abstract][Full Text] [Related]
35. Randomized, comparative trial on the sustained efficacy of topical imiquimod 5% cream versus conventional ablative methods in external anogenital warts.
Schöfer H; Van Ophoven A; Henke U; Lenz T; Eul A
Eur J Dermatol; 2006; 16(6):642-8. PubMed ID: 17229604
[TBL] [Abstract][Full Text] [Related]
36. 5-FU for genital warts in non-immunocompromised individuals.
Batista CS; Atallah AN; Saconato H; da Silva EM
Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD006562. PubMed ID: 20393949
[TBL] [Abstract][Full Text] [Related]
37. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
Nicolaidou E; Kanelleas A; Nikolakopoulos S; Bezrodnii G; Nearchou E; Gerodimou M; Papadopoulou-Skordou E; Paparizos V; Rigopoulos D
Indian J Dermatol Venereol Leprol; 2021; 87(5):666-670. PubMed ID: 31650979
[TBL] [Abstract][Full Text] [Related]
38. Outpatient regimens to reduce COVID-19 hospitalisations: a systematic review and meta-analysis of randomized controlled trials.
Sullivan DJ; Focosi D; Hanley DF; Cruciani M; Franchini M; Ou J; Casadevall A; Paneth N
medRxiv; 2023 Jun; ():. PubMed ID: 35665014
[TBL] [Abstract][Full Text] [Related]
39. Dressings and topical agents for treating pressure ulcers.
Westby MJ; Dumville JC; Soares MO; Stubbs N; Norman G
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD011947. PubMed ID: 28639707
[TBL] [Abstract][Full Text] [Related]
40. Topical imiquimod: a review of its use in genital warts.
Perry CM; Lamb HM
Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
